Apple to roll out hypertension detection on smart watch after FDA nod
Feature will be available on Apple Watch Series 9, Series 10, Series 11, and Ultra 2 and Ultra 3 smartwatches
Apple is set to unveil the latest hypertension detection feature in its smartwatch by next week, after Food and Drug Administration (FDA) clearance on Thursday, Bloomberg News reported.
Apple and the FDA did not immediately respond to Reuters' requests for comment.
The company unveiled a blood pressure monitor in its latest Apple Watch at the September 9 event, where it also introduced a refreshed iPhone lineup, including a slimmer iPhone Air.
The feature, pending regulatory approval, will not detect every case of high blood pressure, but could alert about a million people, Apple said.
Available in 150 countries, the tool will use data from the watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over 30 days, the report said, citing Apple.
The feature will be available on the Apple Watch Series 9, Series 10, Series 11, and its more expensive Ultra 2 and Ultra 3 smartwatches, Bloomberg News said.
-
Real-life ‘Project Hail Mary’ moment: 45 planets that may support alien life discovered -
CERN successfully transports antimatter for first time in historic breakthrough -
Astronomers spot solar system lookalike 87 light-years away -
From Moon base to nuclear spacecraft: Inside NASA’s strategic overhaul to win space race against China -
Northern lights wane, but watch for midnight surprise to dazzle the sky -
NASA, South Korea team up for L4 deep space exploration mission -
Scientists use ‘Space Archaeology’ to rebuild hidden history of giant spiral galaxy -
How to see NASA’s SLS rocket before the Artemis II launch: Here’s everything to know
